![Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c9aea0ae-150f-43d0-b8e2-0f8e986bf2cd/hepr13821-fig-0003-m.jpg)
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library
![Basic concept of liver fibroscan. CAP, controlled attenuation parameter. | Download Scientific Diagram Basic concept of liver fibroscan. CAP, controlled attenuation parameter. | Download Scientific Diagram](https://www.researchgate.net/publication/318791489/figure/fig3/AS:522192308969472@1501511756179/Basic-concept-of-liver-fibroscan-CAP-controlled-attenuation-parameter.png)
Basic concept of liver fibroscan. CAP, controlled attenuation parameter. | Download Scientific Diagram
![Changes in hepatic steatosis (CAP) and fibrosis (LSM) by fibroscan post... | Download Scientific Diagram Changes in hepatic steatosis (CAP) and fibrosis (LSM) by fibroscan post... | Download Scientific Diagram](https://www.researchgate.net/publication/353070137/figure/fig1/AS:1043170632679444@1625722668529/Changes-in-hepatic-steatosis-CAP-and-fibrosis-LSM-by-fibroscan-post-surgery.png)
Changes in hepatic steatosis (CAP) and fibrosis (LSM) by fibroscan post... | Download Scientific Diagram
![Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/asset/237b6cc2-db03-407a-a4f3-d3e37f33891b/gr2.jpg)
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
![Cureus | Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease | Article Cureus | Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease | Article](https://assets.cureus.com/uploads/figure/file/230475/lightbox_47b20e30d1d611eb8e135b93e25632b3-Figure-1-.png)
Cureus | Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease | Article
![PDF] Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | Semantic Scholar PDF] Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/37d796837f3e6b62f1a175e4258b7ecc5e7e91d0/43-Table3-1.png)
PDF] Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | Semantic Scholar
A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis | PLOS ONE
![Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589555921001579-ga1.jpg)
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect
![Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508519301052-fx1.jpg)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
![Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan](https://www.mdpi.com/diagnostics/diagnostics-10-00159/article_deploy/html/images/diagnostics-10-00159-g001.png)
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
![Table 3 from The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. | Semantic Scholar Table 3 from The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eb5b484e12cb14cd27afc429c89250458a83eef3/4-Figure1-1.png)